1 5 1 3 a r t I C l e S Speech and language endow human beings with unrivalled refinement and breadth in their social communications. In autism spectrum disorder (ASD), these communicative abilities can be severely compromised along with other problems related to social communication and repetitive behavior 1 . The neural mechanisms underlying language difficulties in individuals with ASD present a challenge to neuroscientists 2 , but neuroimaging studies have detected aberrant neuronal activity and connectivity in the neocortex and striatum of individuals with ASD 3,4 . We were struck by the parallels between these findings and findings linking mutations of the FOXP2 gene to spoken language disabilities. In both individuals with ASD and those with FOXP2 mutations, corticostriatal dysfunction has been found, along with behavioral problems in humans and in mutant mouse models 5-9 . We therefore sought signaling pathways within corticostriatal circuits that could link these two functional domains.
Speech and language endow human beings with unrivalled refinement and breadth in their social communications. In autism spectrum disorder (ASD), these communicative abilities can be severely compromised along with other problems related to social communication and repetitive behavior 1 . The neural mechanisms underlying language difficulties in individuals with ASD present a challenge to neuroscientists 2 , but neuroimaging studies have detected aberrant neuronal activity and connectivity in the neocortex and striatum of individuals with ASD 3, 4 . We were struck by the parallels between these findings and findings linking mutations of the FOXP2 gene to spoken language disabilities. In both individuals with ASD and those with FOXP2 mutations, corticostriatal dysfunction has been found, along with behavioral problems in humans and in mutant mouse models [5] [6] [7] [8] [9] . We therefore sought signaling pathways within corticostriatal circuits that could link these two functional domains.
Human FOXP2 has been shown to interact with several known ASD-risk genes, including CNTNAP2, MET and uPAR (also known as PLAUR) [10] [11] [12] , but what links FOXP2 and these ASD-risk genes to specific neural circuits with defined neurological functions has not been clear. Nor is it known how such interactions could alter the development of language-related circuits in ASD brains. Given the potential involvement of the striatum in both ASD and language dysfunction, we searched for evidence that might link influences of ASD-risk genes and language-linked FOXP2 during postnatal striatal development, a time of particular vulnerability in ASD. We focused on ASD candidate genes associated with synapse formation, which is at risk in ASD 13, 14 .
We chose for study myocyte enhancer factor 2C (MEF2C), which is suggested as a possible ASD risk gene [15] [16] [17] , one of 175 FOXP2 targets identified by chromatin-immunoprecipitation (ChIP)-chip analysis of human basal ganglia during development 18 and known to be an intellectual disability risk gene 19 . Mef2c has been shown to regulate negatively dendritic spines and excitatory synapses in hippocampal neurons and in cultured striatal neurons [20] [21] [22] [23] . Here we demonstrate in mice that Mef2c also negatively regulates synaptogenesis in the striatum in vivo, but that negative interactions between Foxp2 and Mef2c lead to repression of the effects of Mef2c coinciding spatially and temporally with the development of corticostriatal connections during early postnatal development. We show that Foxp2 can suppress Mef2c through direct DNA binding and that the negative Foxp2-Mef2C signaling interactions have specific synaptic and behavioral effects including control of ultrasonic vocalizations (USVs) in young mouse pups. We suggest that negative Foxp2-Mef2C interactions could allow cortical fibers to synapse progressively onto striatal neurons, thus building the corticostriatal pathway by de-repression of synaptogenesis in the striatum. Such Foxp2-Mef2C signaling could provide a valuable model for identifying candidate molecular mechanisms underlying developmental defects in corticostriatal circuits.
RESULTS

Progressive dissociation of striatal Foxp2 and Mef2C
We performed immunostaining for Mef2C and Foxp2 in the mouse brain with antibodies validated by the absence of corresponding Fig. 1a-f ). Mef2C and Foxp2 colocalized in many individual striatal projection neurons (SPNs) at birth, but their expression patterns soon became complementary and non-overlapping ( Figs. 1 and 2 ). This inverse patterning was first evident in the striosome compartment of the striatum, where we found the earliest incoming corticostriatal terminals as marked by vesicular glutamate transporters 1 (VGluT1; Fig. 1a ). During the early postnatal (P) period, P0-P4, striosomes, marked by dopamine-and cAMP-regulated neuronal phosphoprotein (DARPP)-32, were nearly devoid of Mef2C despite strong Mef2C expression in the surrounding matrix (Figs. 1b and 2d) . Strong Foxp2 expression, by contrast, was found in striosomes ( Fig. 1) . By P8 and P14, the inverse expression patterns of Foxp2 and Mef2C had extended across the striatum (Fig. 2b,c,f) , paralleled by a progressive expansion of the corticostriatal innervation from the striosomes to the entire striatum (Fig. 2a-c) 24 , with dorsolateral expansion leading slightly (Fig. 2g) . This striking progression from colocalization to dissociation of Mef2C and Foxp2 expression coincided with the postnatal time period during which corticostriatal axonal collaterals arborize and the dendritic spines of SPNs develop [24] [25] [26] , suggesting that Mef2C and Foxp2 might oppositely regulate corticostriatal synapse formation.
Foxp2 and Mef2c inversely control corticostriatal synaptogenesis
To examine the relationship of Foxp2 and Mef2C expression to the development of the corticostriatal projection system, we analyzed synaptogenesis in Mef2c knockout mice (Nestin-cre;Mef2c fl/fl ) 21 and Foxp2 knockout (Foxp2 −/− ) mice 8 , and also analyzed synaptogenesis in Foxp2 humanized mice (Foxp2 H/H ) 8 as a gain-of-function model. We identified corticostriatal synapses with VGluT1 as a presynaptic marker 27 and postsynaptic density protein 95 (PSD-95) and glutamate receptor 1 (GluR1) as postsynaptic markers (Supplementary Fig. 1g ). We focused on P12-P14, by which time Foxp2 was expressed throughout the striatum and Mef2C was nearly absent except far medially (Fig. 2h) .
In the Foxp2 −/− mice, western blots of striatal VGluT1 and PSD-95 proteins and immunostaining of striatal GluR1 showed that these synaptic markers all were reduced relative to those in wild-type mice ( Fig. 3a and Supplementary Fig. 2a-c) , but these markers were increased in the striatum of Foxp2 H/H mice ( Fig. 3b and  Supplementary Fig. 2d-f) , suggesting that Foxp2 positively regulates striatal synaptogenesis. By contrast, Mef2c negatively regulated striatal synaptogenesis. VGluT1 and PSD-95 proteins and GluR1 immunostaining significantly increased in the striatum of Nestincre;Mef2c fl/fl conditional Mef2c-knockout mice relative to control Nestin-cre;Mef2c +/+ mice ( Fig. 3c and Supplementary Fig. 2g-i) . Thus, Foxp2 and Mef2C had opposite effects on synaptogenesis in the developing striatum.
Markers of striosomes (µ-opioid receptor 1, MOR1) and of the matrix (calcium and diacylglycerol-guanine nucleotide exchange factor I, CalDAG-GEFI) showed that striosome-matrix compartmentation was maintained in the three genotypes ( Supplementary  Fig. 3a-f) . No abnormal cell death was found in P0 or P8 Foxp2 −/− mice, nor in Nestin-cre;Mef2c fl/fl mice at embryonic day (E) 18.5 and P8, as assayed by terminal deoxynucleotidyl transferase dUTP nickend labeling (TUNEL) staining and immunostaining for activated caspase3 ( Supplementary Fig. 3i-r) . The alterations in synaptic markers were thus likely not secondary to loss of compartmentation or to widespread cell death in the mutant mice.
Foxp2 and Mef2c oppositely regulate SPN spinogenesis
The dendritic spines of striatal SPNs are the main sites of corticostriatal synapses. We examined the development of these synapses in the three mouse genotypes (Fig. 3d-f, Supplementary Fig. 4 and Supplementary  Tables 1-3 ). Golgi staining in P12 Foxp2 −/− mice showed reductions in the total spine density of SPNs of 14.0% dorsolaterally and 19.1% dorsomedially (Fig. 3d, Supplementary Fig. 4a and Supplementary Table 1) . In heterozygous Foxp2 +/− mice, only the most mature spine types 28 were reduced (Fig. 3d, Supplementary Fig. 4a and Supplementary  Table 1) , a finding potentially relevant to pathophysiology in KE patients, who carry heterozygous FOXP2 R553H missense mutations 9 . In the positive control mice carrying humanized Foxp2 H/H , SPN spine densities were increased both dorsolaterally and dorsomedially relative to those in wild-type littermates (Fig. 3e, Supplementary Fig. 4b and Supplementary Table 2) . We microinjected HSV-Cre-GFP viruses into the striatum of P2 Foxp2 H/H mice carrying loxP-flanked (floxed) human versions of Foxp2 alleles 8 . Immunostaining demonstrated a loss of Foxp2 protein expression in HSV-Cre-GFP virus-infected cells ( Supplementary Fig. 5d-e) , and this postnatal deletion of Foxp2 H/H decreased spines by 68% in HSV-Cre-GFP virus-infected SPNs at P8 (Fig. 3g) . These findings suggested that Foxp2 positively regulated synaptogenesis but that Mef2C negatively regulated synaptogenesis, as found in hippocampal neurons [20] [21] [22] .
We used in utero electroporation to overexpress Foxp2 in wild-type striatal cells. Introduction of a Foxp2 plasmid coexpressing EYFP into the E13.5 striatal primordium increased dendritic spine numbers, as tested by EYFP and GFP immunostaining of P14 SPNs (Fig. 3h) . Conversely, spine density was significantly increased in striatal SPNs in Nestin-cre;Mef2c fl/fl mice relative to control Nestin-cre;Mef2c +/+ mice for all but the least mature subtypes (Fig. 3f, Supplementary  Fig. 4c and Supplementary Table 3 ). 
a r t I C l e S
We also microinjected HSV-Cre-GFP virus into the striatum of P2 Mef2c fl/fl pups and examined their brains at P8. Immunostaining confirmed loss of Mef2C protein expression in HSV-Cre-GFP virusinfected cells (Supplementary Fig. 5a-c) and indicated significant increases in spine counts in the HSV-Cre-GFP virus-infected SPNs (Fig. 3i) . Intrastriatal injection of HSV-Cre-GFP viruses in Mef2c fl/fl mice at P14-P15, when Mef2C expression already was low (Fig. 2h) , showed no detectable changes in dendritic spines of SPNs at P19-P20 (Fig. 3j) . Finally, we overexpressed Mef2c by in utero electroporation of pcBIG-Mef2C-VP16 plasmids into the E12.5 striatal primordium of wild types. This procedure decreased the number of spines in P14 SPNs (Fig. 3k) . These findings identify Mef2C as a negative regulator of spine and synapse formation in SPNs of the developing postnatal striatum, consonant with in vitro work on Mef2-class proteins 23 .
In (Fig. 3l) . In P8 Foxp2 −/− mice, mEPSC frequency was decreased in SPNs but mEPSC amplitude was increased compared to wild type (Fig. 3m) . In P14 Nestin-cre;Mef2c fl/fl brains, mEPSC frequency, but not amplitude, was increased in SPNs relative to control Nestin-cre;Mef2c +/+ mice (Fig. 3n ). These findings demonstrate that synaptic activity in striatal SPNs is positively regulated by Foxp2 but negatively regulated by Mef2C, consistent with our anatomical findings (Fig. 3,  Supplementary Fig. 4 and Supplementary Tables 1-3 ).
Foxp2 suppresses Mef2C expression in striatal SPNs
The opposing functions of Mef2c and Foxp2 in regulating corticostriatal synapse formation and SPN spinogenesis, and their striking spatiotemporal dissociation during neonatal development, suggested that the positive regulation of spine and synapse formation in striatal SPNs by Foxp2 might depend on its ability to suppress Mef2c. As an initial probe for this potential interaction, we asked whether the near-absence of Mef2C expression in striosomes in the normal neonatal striatum could be reversed by deletion of Foxp2. We found a r t I C l e S striking de-repression of Mef2C expression in striosomes in the P7 Foxp2 −/− striatum ( Fig. 4a,b) , with the striosome predominance of immunofluorescence intensity of Mef2C-positive cells increased in the Foxp2 −/− knockout mice compared to levels in wild types ( Fig. 4c) . In western blots, Mef2C protein levels were increased by 68.3% over control levels in the P12 Foxp2 −/− striatum ( (Fig. 4e) . In quantitative real-time PCR (qRT-PCR) assays, Mef2c mRNA was increased in (Fig. 4g) .
In vitro overexpression of Foxp2 in the Neuro2A cell line was sufficient to decrease Mef2C protein by 23.5% (Fig. 4h) . These findings are consistent with an antagonism of Mef2C by Foxp2 in the striatum. Mef2C was persistently expressed in neocortex of postnatal wild-type mice ( Supplementary Fig. 1h-j) . We found no changes in Mef2C protein levels or numbers of Mef2C-positive cells in the neocortex of P8 Foxp2 −/− mice ( Supplementary Fig. 6a-d) .
We tracked striatal Mef2C and Foxp2 protein levels by western blot analysis from P4 to P21. For Foxp2 knockout striatum, at P4 the levels of Mef2C and the synaptic markers VGluT1, PSD-95 and GluR1 were not different from controls ( Supplementary  Fig. 6e ), but by P8 there was an increase of Mef2C and decreases of VGluT1, PSD-95 and GluR1 (Supplementary Fig. 6f) , patterns maintained at P12 (Supplementary Fig. 6g ). In the Foxp2 H/H striatum, Mef2C was decreased, and VGluT1 and GluR1 were increased as early as P4 relative to controls (Supplementary Fig. 6h ) and remained elevated at P8 and P21 ( Supplementary Fig. 6i,j) . These results delineated consistent negative interactions of Foxp2 and Mef2C in their effects on striatal synaptogenesis detectable around P4-P8 and persisting for at least 3 postnatal weeks, suggesting that Foxp2 could act to repress Mef2c expression in the striatum.
Mef2c is a direct downstream target gene of Foxp2
One mechanism by which repression of Mef2C by Foxp2 could occur would be if the Mef2c gene were to contain the canonical FOXP2 binding site, CAAATT, and the binding site core, AAAT (ref. 18 ). Foxp2 binds to DNA by dimerization 29 . We found two pairs of putative Foxp2 binding sites in the second intron of the F (2,106) = 34.658, P = 0; for thin/filopodial, F (2,106) = 2.012, P = 0.139; for mushroom, F (2,106) = 5.182, P = 0.007; for branched, F (2,106) = 9.555, P = 0.000153; for multi-branched, F (2,106) = 5.965, P = 0.004; for atypical, F (2,106) = 11.944, P = 0.000021; for sum, F (2,106) = 38.448, P = 0). Student's t test are used in b (for VGluT1, t (8) = −3.155, P = 0.014; for PSD-95, t (8) = 2.518, P = 0.036), c (for PSD-95, t (4) = −6.442, P = 0.003; for VGluT1, t (4) = −2.795, P = 0.049; e (for stubby, t (29) = 0.623, P = 0.538; for thin/filopodial, t (29) = −2.249, P = 0.032; for mushroom, t (29) = −2.041, P = 0.050; for branched, t (29) = −2.300, P = 0.029; for multi-branched, t (29) = −3.525, P = 0.001; for atypical, t (29) = 0.769, P = 0.448; for sum, t (29) = −4.216, P = 0.000383), g (t (31) = 9.429, P = 0), h (t (23) = −7.612, P = 0.000001), i (t (26) = −3.509, P = 0.002), j (t (38) = −1.122, P = 0.269), k (t (28) = 9.453, P = 0), l (for frequency, t (13) = 2.890, P = 0.013; for amplitude, t (13) = −2.2505, P = 0.043) and n (for frequency, t (14) = −4.022, P = 0.001; for amplitude, t (14) = −1.131, P = 0.237). Mann-Whitney U test is used in m (U = 167.5, P = 0.009 for frequency; U = 273, P = 0.471 for amplitude). a r t I C l e S (−1837 bp) plus CAAATT (−1788 bp), relative to translation initiation site A+1TG (Fig. 5a) . With ChIP-quantitative PCR (ChIP-qPCR) assays of mouse striatal cells at E16, we found that Foxp2 antibody, but not control IgG antibody, immunoprecipitated a DNA fragment containing the two pairs of Foxp2 motifs (Fig. 5b) . Thus, Foxp2 can bind directly to this region containing the canonical Foxp2 binding motifs in vivo.
We cloned this DNA region into a pGL3-c-Fos-Luciferase (Luc) reporter gene construct and cotransfected the Mef2C-pGL3-c-Fos-Luc plasmid into Neuro2A cells with a Foxp2 expression plasmid. Transfection of the mouse Foxp2 gene repressed Luc activity by 29% compared to mock controls (Fig. 5c) . Transfection of the human FOXP2 gene, but not the hFOXP2 R553H mutant lacking DNA binding capacity, resulted in a similar (31%) decrease of Luc activity (Fig. 5c) .
We next mutated the sequences of the ACAAAT plus AAAT motifs to ACGGGT plus GGGT (MT1) and the sequences of the AAAT plus CAAATT motifs to GGGT plus CGGGTT (MT2) by site-directed mutagenesis. The repression of Luc reporter gene activity was abolished when either Mef2C-MT1-c-Fos-Luc or Mef2C-MT2-c-Fos-Luc mutant plasmid was cotransfected with mouse Foxp2 expression plasmid (Fig. 5c) . Loss of repression of Luc activity also occurred with cotransfection of human FOXP2 gene and the MT1 or MT2 mutant reporter gene constructs (Fig. 5c) . These results suggest that Foxp2 directly binds to the two canonical Foxp2 binding motifs to functionally repress the capacity for Mef2c gene expression. We looked for and identified putative FOXP2 binding motifs in the promoter region of the human MEF2C gene (Supplementary Fig. 7) , a finding potentially linking our mouse work to the suggestion that human MEF2C gene is a putative target gene of FOXP2 in human embryonic basal ganglia tissue 18 . We tested this possibility in Foxp2 +/− heterozygotes, mouse models of humans carrying one allele of the FOXP2 mutation. We confirmed that these Foxp2 +/− mutants had abnormal USVs ( Supplementary  Fig. 8a ) and then examined the effects of inactivation of one allele in (Fig. 6a-d and Supplementary Fig. 8b ). The fact that we found no marked differences in USV features between Dlx5/6-cre;Foxp2 +/+ ;Mef2c fl/+ mice, which had normal Foxp2 but a deleted Mef2c allele, and Dlx5/6-cre;Foxp2 +/+ ;Mef2c +/+ mice, which had normal Foxp2 and normal Mef2c alleles, ruled out the possibility that the effect of Mef2C reduction was mediated through a pathway independent of Foxp2 ( Supplementary Fig. 8c) .
Mef2c deletion rescues USVs and SPN spines in
The single-allele genetic reduction of Mef2c levels also substantially rescued VGluT1 and PSD-95 protein levels in the striatum of Mef2c-deficient Dlx5/6-cre;Foxp2 +/− ;Mef2c fl/+ mice compared to those in control Dlx5/6-cre;Foxp2 +/− ;Mef2c +/+ mice (Fig. 6e) . SPN spine counts were markedly increased dorsolaterally and dorsomedially (Fig. 6f,  Supplementary Fig. 4d and Supplementary Table 4) . These synaptic rescue effects were evident in both striosome and matrix compartments, judging by significantly increased immunostaining for GluR1 (Fig. 6g-i) .
To test the possibility that the spine rescue occurred because of general effects of genetic deletion on development, we restricted deletion of Mef2c specifically in the neonatal striatum by microinjecting HSV-Cre-GFP virus into the striatum of P2 Foxp2 +/− ;Mef2c fl/+ pups and performing GFP immunostaining and Golgi assays at P8. This striatum-specific decrease of Mef2C resulted in significant increases in dendritic spines in HSV-Cre-GFP virus-infected SPNs of Foxp2 +/− ;Mef2c fl/+ mice compared to the spines of SPNs in control Foxp2 +/− ;Mef2c +/+ mice (Fig. 6j) . The USV events and frequency-jump scores of the pups were also rescued in the HSV-Cre-GFP;Foxp2 +/ − ;Mef2c fl/+ pups (Fig. 6k,l and Supplementary Fig. 8d) .
These multiple lines of evidence directly suggest that corticostriatal synaptic protein levels are suppressed by Mef2C and can be rescued along with behavioral rescue of USVs by expression of Foxp2. These findings suggest that Mef2c acts downstream of Foxp2 to regulate synaptic wiring of corticostriatal circuits that contribute to vocalization. (Fig. 6a-d,k-l) , a r t I C l e S we expected that deletion of Mef2c would alter USVs. We tested this possibility and found that the numbers of emitted USVs were significantly reduced in the Nestin-cre;Mef2c fl/fl mice compared to those in control Nestin-cre;Mef2c +/+ mice (Fig. 7a) and that the deficit included significant reductions in many USV features (Fig. 7a-d,j) , though some USV features were unaffected (Fig. 7e-i a r t I C l e S deletion can result in a deficit in USVs, a vocalization phenotype, adding evidence consistent with our working hypothesis that Foxp2-Mef2C signaling could regulate vocalization along with regulating corticostriatal connectivity.
USV deficits occur in
DISCUSSION
Our findings provide causal evidence that Mef2C is directly implicated in the conjoint deleterious behavioral and morphological effects of reductions in Foxp2. We demonstrated that Mef2C is a negative regulator of synapse formation in the projection neurons of the developing striatum and that Mef2C expression is itself a direct target of gene suppression by the Foxp2 gene in these neurons ( Supplementary  Fig. 9 ). Thus, by negatively regulating Mef2c, Foxp2 can promote the formation of the massive corticostriatal connectivity that is known to be functionally important in behavior. Our findings suggest that Foxp2 acts in the early postnatal period by coordinately promoting corticostriatal synaptogenesis and retarding the expression of Mef2C in the striatum. Deletion of Foxp2 increased neonatal striatal Mef2C expression and, in parallel, decreased corticostriatal synaptogenesis and spinogenesis of striatal SPNs. Engineered expression of humanized Foxp2 in mouse had opposite effects on the developing corticostriatal circuits and striatal neurons. Our evidence that canonical Foxp2 binding sites are required for the Foxp2 inhibition of Mef2C expression suggests that there are direct molecular interactions between Foxp2 and Mef2C. We found that intrastriatal as well as genome-wide decreases in Mef2C could rescue defects in USVs and striatal spinogenesis otherwise occurring in Foxp2 mutants. Finally, our study of USVs suggests that these Foxp2-Mef2C interactions exert orchestrated control over corticostriatal systems affecting social vocalization in neonates. Our findings are based on mouse models and so might not be relevant to clinical conditions. Given that MEF2C has been suggested as an ASD candidate risk gene and is known to be related to intellectual disability [15] [16] [17] 19 and that FOXP2 has been identified as a language-associated gene 9 , a plausible hypothesis raised by our findings is that the Foxp2-Mef2C interactions we demonstrate here, and their profound effects on corticostriatal circuitry, could be relevant to mechanisms underlying spoken language dysfunction in ASD. More generally, such interactions, controlling the development of the corticostriatal system, could be relevant to a range of normal and abnormal functions in which this massive corticostriatal circuitry has been implicated clinically, notably including Huntington's disease.
Foxp2-Mef2C control of USVs and corticostriatal circuit
The potential behavioral significance of interactions between Foxp2 and Mef2C was demonstrated by assays of USVs in mice that lacked one allele of Foxp2 and one allele of Mef2c (Dlx5/6-cre;Foxp2 +/− ; Mef2c fl/+ mice). Genetic reduction of Mef2c levels rescued four of the seven USV defects exhibited by Foxp2 heterozygotes and increased VGluT1 and PSD-95 synaptic proteins in the striatum relative to levels of the corresponding proteins in control Dlx5/6-cre; Foxp2 +/− ;Mef2c +/+ mice. The USV and spine formation deficits were also partially rescued by selective early postnatal reduction of Mef2C. While not ruling out other contributions, these findings support the striatal specificity of Foxp2-Mef2C interactions in regulating synaptogenesis in SPNs and vocalization behavior of the pups. We also found a clear correlation between synaptic alterations in Dlx5/6-cre; Foxp2 +/− ;Mef2c +/+ mice (Foxp2 heterozygotes) and the USV deficits in these mice, further linking anatomical and functional control by Foxp2-Mef2C signaling.
Foxp2 as a molecular key to unlock Mef2C-induced inhibition Our findings demonstrate that interactions between Foxp2 and Mef2c are required for establishing the normal synaptic connectivity of corticostriatal circuits. In the hippocampus, Mef2 protein interacts with the ASD-risk genes FMRP and Pcdh10 to induce degradation of PSD-95 protein, which eliminates excitatory synapses 22 . This work suggests a central role for Mef2 in negative regulation of hippocampal synapses. Our findings identify Foxp2 as a molecular key to unlock the inhibition of striatal synapse formation imposed by Mef2C, thereby . Outlying values are marked as circles. *P < 0.05, **P < 0.01, ***P < 0.001. a r t I C l e S allowing the initiation of synaptic connectivity of corticostriatal circuits within the striatum. Our data support a postnatal role, as early as P2, for Foxp2-mediated repression of Mef2C in the regulation of spinogenesis. As spines start to grow in postnatal SPNs, Mef2c, which inhibits spine formation, presumably must be downregulated to permit the progression of spine formation in SPNs. The gradual decrease in Mef2C in the postnatal striatum and the maintenance of these low levels at least until P14 are consistent with this hypothesis. The evidence of increased spine formation in SPNs by postnatal deletion of Mef2c at P2 further supports this working model. Our experiments did not clarify whether Mef2C acts to prune exuberant striatal SPN synapses or to inhibit synapse formation in these SPNs. However, given our observation that Mef2C is strongly expressed in striatal matrix SPNs before these SPNs are innervated by corticostriatal axon terminals in newborn striatum (Fig. 1b) , an intriguing possibility is that Mef2C functions as a molecular gate to prevent immature synapse formation unless it is triggered by an appropriate input. This gate-control role for Mef2C would suggest that a rigorously timed and specific molecular mechanism is implemented for developmental control of synaptic wiring of corticostriatal circuits. We suggest that Foxp2 inhibition of Mef2c could provide such a mechanism, potentially through direct DNA binding of Foxp2 to Mef2c, and that defects in this inhibition by Foxp2 could have deleterious effects. ChIP-chip analysis has identified MEF2D in addition to MEF2C as potential target genes of FOXP2 in embryonic human brains 18 . For other members of Mef2 family, in contrast to the low levels of Mef2C in the mature striatum, levels of Mef2D and Mef2A are high in the mature mouse striatum, where they have been implicated in the plasticity of dendritic spines in SPNs induced by exposure to cocaine 32 . In the hippocampus, dendritic spine formation is negatively regulated by Mef2c in the dentate gyrus of hGFAP-cre;Mef2c mice 21 but not in the CA1 region of hGFAP-cre;Mef2a;Mef2d double-knockout mice or hGFAP-cre;Mef2a;Mef2d triple-knockout mice, apparently reflecting low Mef2C expression in the CA1 region 33 . Postnatal deletion of Mef2c also results in increased spines in the dentate gyrus in CaMKIIcre;Mef2c knockout mice 34 .
Comparison of Foxp2 in striatal and cortical synaptogenesis
In contrast to the developmental downregulation of Mef2c in postnatal striatum, Mef2C was persistently expressed in postnatal neocortex of wild-type mice. Our finding that Mef2C was not altered in the neocortex of Foxp2 knockout mice suggests that Foxp2-Mef2C interaction does not dominate the development of cortical neurons, but it leaves open the possibility of some compensatory mechanism in the neocortex. In cultured neocortical neurons, Foxp2 has been found to regulate negatively excitatory synaptogenesis via inhibition of SPRX2, an epilepsy-and language-associated gene 35 . The positive action of Foxp2-Mef2C signaling on synaptogenesis in the striatum, shown here, and the reported negative action of Foxp2-SPRX2 signaling on synaptogenesis in cortical neurons, suggest a commanding and highly differentiated role for Foxp2 in developmental control of neural circuits that have been related to language. In the avian model of vocal communication, knocking down songbird FoxP2 in Area X decreases spine density in neurons of Area X and decreases vocal motor learning 36, 37 . Our findings add to evidence for a controlling role for Foxp2, explicitly by introducing its ability to suppress Mef2c as a potential critical mechanism contributing to the control of vocalization.
Potential clinical relevance of Foxp2-Mef2C interactions Our findings suggest a molecular mechanism by which Foxp2 can regulate excitatory corticostriatal synapses onto striatal projection neurons in mice through suppression of Mef2c, whose progressive downregulation is synchronized spatially and temporally with the development and synaptogenesis of corticostriatal circuits. Our evidence specifically suggests that Foxp2 transcriptionally suppresses the spinogenesis suppressor Mef2c, thereby allowing corticostriatal synaptogenesis.
There is no direct evidence from our work that these interactions occur in the human brain or that they relate to human conditions including ASD and speech and language development. FOXP2 is considered a "language-related gene" 9 , but its precise relation to speech and language is still a matter of study. Similarly, MEF2C has been identified as a candidate ASD gene [15] [16] [17] , but evidence for linkage of MEF2C mutations to ASD is still incomplete. MEF2C mutations have been linked to phenotypes including mental retardation in humans 15, 19 , a matter of current research. It is known, however, that MEF2C is a putative target gene of FOXP2 in the developing human basal ganglia 18 , and our findings suggest that the human FOXP2 protein is at least as effective as, or more effective than, the mouse Foxp2 protein in promoting synapse and complex spine formation in SPNs in the mouse striatum. Our findings raise the possibility that the interactions we have documented in the mouse may hold in some form in humans. If so, our findings could be interpreted as relevant to a molecular linkage between the putative ASD candidate gene MEF2C and the putative language-associated gene FOXP2. Notably, Mef2c is regulated by MeCP2, a well-established Rett syndrome gene with broad effects 38 , and MEF2 is implicated in regulation of the ASD-risk genes DIA1 and PCDH10 (ref. 39 ). Thus, our findings could be relevant in the context of multiple ASD-risk genes interacting in signaling networks for neuronal development 13, 14 .
Human patients with MEF2C deletion and mutation have complex neurological syndromes 15, 16, 19 . In addition to defective language communication, stereotypic behaviors, potentially linked to striosomes 40 , have been reported in patients with MEF2C deletion and mutation 15, 19 and in the Mef2c knockout mouse model of ASD 31, 41 . Our findings indicate that part of the etiology of MEF2C-related ASD symptoms could be rooted in the basal ganglia. We raise the possibility that defective FOXP2-MEF2C signaling affecting developing corticostriatal synaptic circuits could be a previously underestimated pathologic mechanism in conditions characterized by corticostriatal abnormalities.
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